✦ LIBER ✦

A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule

✍ Scribed by L. Serrone; M. Zeuli; T. Gamucci; M. Nardi; F. Cognetti

Publisher: Springer
Year: 2001
Tongue: English
Weight: 77 KB
Volume: 47
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800000219

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of sequential, dose-e

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

✍ Carsten Bokemeyer; Anke Franzke; Jörg T. Hartmann; Christoph Schöber; Lubomir Ar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

ide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in

A phase II trial of temozolomide as a 6-

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish Group for Research on Sarcomas

✍ Xavier Garcia del Muro; Antonio Lopez-Pousa; Javier Martin; Jose M. Buesa; Javie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views